Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

DARE stock hub

Daré Bioscience, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DAREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DARE

In the news

Latest news · DARE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-2,145.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DARE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001401914
Company name	Daré Bioscience, Inc.
Country	United States
Country code	US
Cusip	23666P101
Employees	24
Employees Change	1%
Employees Change Percent	4.35
Enterprise value	$18M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US23666P2002
Last refreshed	2026-05-10
Market cap	$40M
Market cap category	Nano-Cap
Price	$2.75
Price currency	USD
Rev Per Employee	42,924.71x
Sector	Healthcare
Sic	2834
Symbol	DARE
Website	https://darebioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.47%
EV Sales Forward	0.93x
EV/Sales	17.46x
FCF yield	-25.65%
P/B ratio	14.03x
P/S ratio	38.87x
PS Forward	2.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	71.29%
Gross Profit	$734,394
Gross Profit Growth	7,406.07%
Net Income	$-13.4M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1,300.66%
Profit Per Employee	$-558,303
ROA	-31.04
Roa5y	-54.82
ROCE	-154.2
ROIC	-2,145.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.85%
Cagr3y	-38.8%
Cagr5y	-30.17%
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth Q	-73.91%
OCF Growth Q	-72.78%
Revenue Growth	10,429.36x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-53.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$32.5M
Cash	$24.7M
Current Assets	$27.1M
Current Liabilities	$23.7M
Debt	$2.7M
Debt Equity	$0.93
Equity	$2.8M
Liabilities	$29.6M
Long Term Assets	$5.4M
Long Term Liabilities	$5.9M
Net Cash	$22.1M
Net Cash By Market Cap	$55.09
Net Cash Growth	53.21%
Net Debt Equity	$-7.76
Tangible Book Value	$2.8M
Tangible Book Value Per Share	$0.2
WACC	9.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Net Working Capital	$-19.2M
Quick ratio	1.07
Working Capital	$3.4M
Working Capital Turnover	$9.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.84%
200-day SMA	1.99
3Y total return	-77.08%
50-day SMA	1.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.39%
All Time High	79.47
All Time High Change	-96.54%
All Time High Date	2017-07-20
All Time Low	1.27
All Time Low Change	116.54%
All Time Low Date	2026-03-19
ATR	0.35
Beta	1.09
Beta1y	1.98
Beta2y	1.3
Ch YTD	42.49
High	2.94
High52	9.19
High52 Date	2025-07-14
High52ch	-70.08%
Low	2.65
Low52	1.27
Low52 Date	2026-03-20
Low52ch	116.54%
Ma50ch	42.34%
Premarket Change Percent	-3.78
Premarket Price	$2.8
Premarket Volume	41,693
Price vs 200-day SMA	38.47%
RSI	58.68
RSI Monthly	43.07
RSI Weekly	60.49
Sharpe ratio	0.3x
Sortino ratio	0.68
Total Return	-31.55%
Tr YTD	42.49
Tr1m	55.37%
Tr1w	17.52%
Tr3m	62.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$12
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.31
Earnings Revenue Estimate	601,600x
Earnings Revenue Estimate Growth	2,265.99x
Operating Income	$-13.6M
Operating margin	-1,315.5
Price target	$10
Price Target Change	$264
Price Target Change Top	$336

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,311,526%
Float Percent	91.43%
Net Borrowing	-1,331,296
Shares Insiders	0.95%
Shares Institutions	8.47%
Shares Out	14,559,502
Shares Qo Q	12%
Shares Yo Y	31.55%
Short Float	1.28%
Short Ratio	1.64
Short Shares	1.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.8M
Average Volume	1,366,594.9x
Bv Per Share	0.2
CAPEX	$-385,278
Ch1m	55.37
Ch1w	17.52
Ch1y	-4.84
Ch3m	62.72
Ch3y	-77.08
Ch5y	-83.39
Ch6m	50.27
Change	-5.5%
Change From Open	-6.46
Close	2.91
Days Gap	1.03
Depreciation Amortization	1,634,486
Dollar Volume	1,540,387.8
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-13.6M
EBITDA	$-11.9M
EPS	$-1.2
F Score	2
FCF	$-10.3M
FCF EV Yield	-57.11x
FCF Per Share	$-0.71
Financing CF	19,277,144
Fiscal Year End	December
Founded	2,015
Investing CF	-385,278
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2024-07-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	1.93
Ma150ch	42.41%
Ma20	2.45
Ma20ch	12.06%
Net CF	9,013,182
Next Earnings Date	2026-05-14
Open	2.94
Optionable	No
Position In Range	34.48
Post Close	2.75
Postmarket Change Percent	-1.42
Postmarket Price	$2.71
Ppne	4,401,245
Pre Close	2.91
Price Date	2026-05-08
Ptbv Ratio	14.09
Relative Volume	0.41x
Revenue	1,030,193x
SBC By Revenue	145.27x
Share Based Comp	1,496,562
Tr6m	50.27%
Us State	California
Volume	560,141
Z Score	-8.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DARE pay a dividend?

Capital-return profile for this ticker.

Performance

DARE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DARE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.5%

Float: +91.4% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DARE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.7

Neutral momentum band

Price vs 200-day MA

+38.5%

50/200-day relationship not available

Beta (5Y)

1.09

Moves roughly with the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About DARE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DARE stock rating?

Daré Bioscience, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DARE analysis?

The full report lives at /stocks/DARE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DARE?

The latest report frames DARE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DARE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.